Worth noting: Lemme GLP-1 was involved in a recent class action lawsuit for false advertising
In clinical trials, a gradual dose-escalation schedule was used specifically to allow the body to adapt and to minimise discomfort
This may be mediated mainly by activating proopiomelanocortin neurons, which, in turn, activate hypothalamic melanocortin 4 receptors (MC4R) that receive projections of POMC fibers, responsible for the anorexigenic activity [130,131]
Packer M, Anker SD, Butler J et al (2020) Cardiovascular and renal outcomes with empagliflozin in heart failure
GLP-1 receptor activation slows gastric emptying, enhances insulin secretion, and suppresses glucagon release from alpha cells
Meaningful weight loss usually develops gradually over months